Literature DB >> 19187568

Evaluating integrated healthcare for refugees and hosts in an African context.

Anais Tuepker1, Chunhuei Chi.   

Abstract

This paper argues on ethical and practical grounds for more widespread use of an integrated approach to refugee healthcare, and proposes a basic model of assessment for integrated systems. A defining element of an integrated approach is an equal ability by refugee and host nationals to access the same healthcare resources from the same providers. This differs fundamentally from parallel care, currently the predominant practice in Africa. The authors put forward a general model for evaluation of integrated healthcare with four criteria: (1) improved health outcomes for both hosts and refugees, (2) increased social integration, (3) increased equitable use of healthcare resources, and (4) no undermining of protection. Historical examples of integrated care in Ethiopia and Uganda are examined in light of these criteria to illustrate how this evaluative model would generate evidence currently lacking in debates on the merit of integrated healthcare.

Mesh:

Year:  2009        PMID: 19187568     DOI: 10.1017/S1744133109004824

Source DB:  PubMed          Journal:  Health Econ Policy Law        ISSN: 1744-1331


  3 in total

1.  Performance of UNHCR nutrition programs in post-emergency refugee camps.

Authors:  Shannon Doocy; Hannah Tappis; Christopher Haskew; Caroline Wilkinson; Paul Spiegel
Journal:  Confl Health       Date:  2011-10-26       Impact factor: 2.723

Review 2.  Intersectoral and integrated approaches in achieving the right to health for refugees on resettlement: a scoping review.

Authors:  Shirley Ho; Dena Javadi; Sara Causevic; Etienne V Langlois; Peter Friberg; Göran Tomson
Journal:  BMJ Open       Date:  2019-07-01       Impact factor: 2.692

3.  Including refugees in disease elimination: challenges observed from a sleeping sickness programme in Uganda.

Authors:  Jennifer J Palmer; Okello Robert; Freddie Kansiime
Journal:  Confl Health       Date:  2017-12-01       Impact factor: 2.723

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.